For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit VaccineTogetherNY.org.
Population Health Sciences

You are here

Publications

Found 248 results
Author [ Title(Desc)] Type Year
Filters: First Letter Of Last Name is C  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
M
Khullar D, Chokshi DA.  2020.  Moving to Action on Place-Based Health.. JAMA. 323(8):698-699.
P
Cea ME, M Reid C, Inturrisi C, Witkin LR, Prigerson HG, Bao Y.  2016.  Pain Assessment, Management, and Control Among Patients 65 Years or Older Receiving Hospice Care in the U.S.. J Pain Symptom Manage. 52(5):663-672.
McHugh M, Shi Y, Ramsay PP, Harvey JB, Casalino LP, Shortell SM, Alexander JA.  2016.  Patient-Centered Medical Home Adoption: Results From Aligning Forces For Quality.. Health Aff (Millwood). 35(1):141-9.
Khullar D, Wolfson D, Casalino LP.  2019.  Patient-Centered Performance Metrics-Reply.. JAMA. 321(18):1829-1830.
Hearld LR, Alexander JA, Shi Y, Casalino LP.  2014.  Pay-for-performance and public reporting program participation and administrative challenges among small- and medium-sized physician practices.. Med Care Res Rev. 71(3):299-312.
Mullangi S, Bhandari R, Thanaporn P, Christensen M, Kronick S, Nallamothu BK.  2020.  Perceptions of resuscitation care among in-hospital cardiac arrest responders: a qualitative analysis.. BMC Health Serv Res. 20(1):145.
Martin P, Bartlett NL, Blum KA, Park S, Maddocks K, Ruan J, Ridling LA, Dittus C, Chen Z, Huang X et al..  2019.  A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphoma.. Blood. 133(11):1201-1204.
Martin P, Bartlett NL, Blum KA, Park S, Maddocks K, Ruan J, Ridling LA, Dittus C, Chen Z, Huang X et al..  2019.  A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphoma.. Blood. 133(11):1201-1204.
Tagawa ST, Vallabhajosula S, Christos PJ, Jhanwar YS, Batra JS, Lam L, Osborne J, Beltran H, Molina AM, Goldsmith SJ et al..  2019.  Phase 1/2 study of fractionated dose lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 ( Lu-J591) for metastatic castration-resistant prostate cancer.. Cancer. 125(15):2561-2569.
Batra JS, Niaz MJunaid, Whang YE, Sheikh A, Thomas C, Christos P, Vallabhajosula S, Jhanwar YS, Molina AM, Nanus DM et al..  2020.  Phase I trial of docetaxel plus lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 (Lu-J591) for metastatic castration-resistant prostate cancer.. Urol Oncol.
Martin P, Ruan J, Furman R, Rutherford S, Allan J, Chen Z, Huang X, DiLiberto M, Chen-Kiang S, Leonard JP.  2019.  A phase I trial of palbociclib plus bortezomib in previously treated mantle cell lymphoma.. Leuk Lymphoma. :1-5.
Martin P, Ruan J, Furman R, Rutherford S, Allan J, Chen Z, Huang X, DiLiberto M, Chen-Kiang S, Leonard JP.  2019.  A phase I trial of palbociclib plus bortezomib in previously treated mantle cell lymphoma.. Leuk Lymphoma. :1-5.
Chaabane S, Chaabna K, Abraham A, Mamtani R, Cheema S.  2020.  Physical activity and sedentary behaviour in the Middle East and North Africa: An overview of systematic reviews and meta-analysis.. Sci Rep. 10(1):9363.
Chaabane S, Chaabna K, Abraham A, Mamtani R, Cheema S.  2020.  Physical activity and sedentary behaviour in the Middle East and North Africa: An overview of systematic reviews and meta-analysis.. Sci Rep. 10(1):9363.
Chaabane S, Chaabna K, Abraham A, Mamtani R, Cheema S.  2020.  Physical activity and sedentary behaviour in the Middle East and North Africa: An overview of systematic reviews and meta-analysis.. Sci Rep. 10(1):9363.